Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 11, 2023
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
[ Thu, May 11th 2023
] - WOPRAI
Jason Butler Maintained (SYRS) at Buy with Decreased Target to $15 on, May 11th, 2023
Jason Butler of JMP Securities, Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Buy with Decreased Target from $16 to $15 on, May 11th, 2023.
Jason has made no other calls on SYRS in the last 4 months.
There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, 0 agree with Jason's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jason
- Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $13 on, Friday, March 3rd, 2023
